Literature DB >> 19913312

Implication of oxidative stress and its correlation with activity of matrix metalloproteinases in patients with Takayasu's arteritis disease.

Nitin Mahajan1, Veena Dhawan2, Sonal Malik1, Sanjay Jain3.   

Abstract

BACKGROUND: Oxidative stress and activation of matrix metalloproteinases (MMPs) together have been widely implicated in various inflammatory vascular disorders. As Takayasu's arteritis (TA) is an inflammatory disorder characterized by destruction of elastic fibers, we hypothesized that oxidative stress and MMPs might play an important role in pathophysiology of the disease.
METHODS: 40 patients with clinically defined TA and equal number of normal, healthy, controls were enrolled in the study. Subjects with TA were further divided into clinically active disease or in remission phase of the disease.
RESULTS: Augmented levels of 8-isoPGF(2α) (238.9±125.7 vs 79.5±29.1 ng/ml), nitrite (NO(2)(-)) (14.9±15.6 vs 3.3±1.7 μM) were observed in TA patients as compared to the controls (p<0.01). Further, 8-iso-PGF(2α) (272.2±117.3 vs 105.9±43.5 ng/ml) and NO(2)(-) (17.9±16.1 vs 3.1±2.5 μM) levels were higher in subjects with active disease vs those in remission (p<0.05). Zymography pattern revealed two bands in the range of 85-92 kDa (MMP-9) and 65-72 kDa (MMP-2). Total gelatinolytic activity was found to be significantly higher in subjects with TA as compared to the controls (p<0.05). Gelatinolytic activity was moderately low in controls and subjects in remission as compared to those with active disease (p>0.05). Further, gelatinolytic activity showed a positive correlation with 8-iso-PGF(2α) and NO levels in patients with TA.
CONCLUSIONS: Increased oxidative stress and MMP activity may play an active role in the progression of Takayasu's arteritis disease.
Copyright © 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19913312     DOI: 10.1016/j.ijcard.2009.09.557

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  7 in total

1.  Development of outcome measures for large-vessel vasculitis for use in clinical trials: opportunities, challenges, and research agenda.

Authors:  Haner Direskeneli; Sibel Z Aydin; Tanaz A Kermani; Eric L Matteson; Maarten Boers; Karen Herlyn; Raashid A Luqmani; Tuhina Neogi; Philip Seo; Ravi Suppiah; Gunnar Tomasson; Peter A Merkel
Journal:  J Rheumatol       Date:  2011-07       Impact factor: 4.666

2.  F-18 FDG PET/CT in the evaluation of Takayasu arteritis: an experience from the tropics.

Authors:  Sampath Santhosh; Bhagwant Rai Mittal; Shankaramurthy Gayana; Anish Bhattacharya; Aman Sharma; Sanjay Jain
Journal:  J Nucl Cardiol       Date:  2014-05-30       Impact factor: 5.952

Review 3.  The role of elastic fibers in pathogenesis of conjunctivochalasis.

Authors:  Jing-Yun Gan; Qing-Song Li; Zhen-Yong Zhang; Wei Zhang; Xing-Ru Zhang
Journal:  Int J Ophthalmol       Date:  2017-09-18       Impact factor: 1.779

Review 4.  Physical Exercise in Managing Takayasu Arteritis Patients Complicated With Cardiovascular Diseases.

Authors:  Yaxin Zhou; Yuan Feng; Wei Zhang; Hongxia Li; Kui Zhang; Zhenbiao Wu
Journal:  Front Cardiovasc Med       Date:  2021-05-12

Review 5.  Acknowledged signatures of matrix metalloproteinases in Takayasu's arteritis.

Authors:  Gang Wu; Nitin Mahajan; Veena Dhawan
Journal:  Biomed Res Int       Date:  2014-09-03       Impact factor: 3.411

6.  Analysis of oxidative stress enzymes and structural and functional proteins on human aortic tissue from different aortopathies.

Authors:  María Elena Soto; Elizabeth Soria-Castro; Verónica Guarner Lans; Eleazar Muruato Ontiveros; Benjamín Iván Hernández Mejía; Humberto Jorge Martínez Hernandez; Rodolfo Barragán García; Valentín Herrera; Israel Pérez-Torres
Journal:  Oxid Med Cell Longev       Date:  2014-07-01       Impact factor: 6.543

7.  Enhanced Liver Fibrosis Score as a Biomarker for Vascular Damage Assessment in Patients with Takayasu Arteritis-A Pilot Study.

Authors:  Maja Stojanovic; Sanvila Raskovic; Vladimir Milivojevic; Rada Miskovic; Ivan Soldatovic; Sanja Stankovic; Ivan Rankovic; Marija Stankovic Stanojevic; Sanja Dragasevic; Miodrag Krstic; Andreas P Diamantopoulos
Journal:  J Cardiovasc Dev Dis       Date:  2021-12-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.